Patent Assignment
Reel/Frame 067152/0523
Assignment of Assignor's Interest
Recorded: 2024-04-18
Pages: 7
Assignors
BETTENCOURT, BRIAN
Executed: 2018-01-31
FITZGERALD, KEVIN
Executed: 2018-01-31
QUERBES, WILLIAM
Executed: 2018-01-31
Assignee
ALNYLAM PHARMACEUTICALS, INC.
300 THIRD STREET, CAMBRIDGE, MASSACHUSETTS, 02142-1110
Covered Property
(1)
Compositions and Methods for Inhibiting Expression of the ALAS1 Gene
Application:
18/630,504 →
Publication:
US 2025/0122505
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 18, 2024
From: DESNICK, ROBERT; YASUDA, MAKIKO
To: ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
Reel/Frame 067152/0591 →
Assignment of Assignor's Interest
Apr 18, 2024
From: BETTENCOURT, BRIAN; FITZGERALD, KEVIN; QUERBES, WILLIAM
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 067152/0697 →
Assignment of Assignor's Interest
Apr 18, 2024
From: DESNICK, ROBERT; YASUDA, MAKIKO
To: ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
Reel/Frame 067153/0103 →
Security Interest
Oct 1, 2025
From: ALNYLAM PHARMACEUTICALS, INC.; SIRNA THERAPEUTICS, INC.
To: BANK OF AMERICA, N.A.
Reel/Frame 072996/0337 →